Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Toxins|April 21, 2022
High Cell Density Cultivation Process for the Expression of Botulinum Neurotoxin a Receptor Binding DomainAlon Ben David, Yoel Papir, Ophir Hazan, et al.
Plos One|January 30, 2014
Evaluating the synergistic neutralizing effect of anti-botulinum oligoclonal antibody preparationsEran Diamant, Bat-El Lachmi, Adi Keren, et al.
Vaccine|November 28, 2017
An in vitro cell-based potency assay for pharmaceutical type A botulinum antitoxinsAmram Torgeman, Eran Diamant, Lilach Levin, et al.
Antimicrobial Agents and Chemotherapy|May 11, 2021
A Novel Running Wheel Mouse Model for Botulism and Its Use for the Evaluation of Postsymptom Antitoxin EfficacyArieh Schwartz, Alon Ben David, Mordechai Hotoveli, et al.
Antimicrobial Agents and Chemotherapy|February 14, 2018
A Novel Rabbit Spirometry Model of Type E Botulism and Its Use for the Evaluation of Postsymptom Antitoxin EfficacyEran Diamant, Avi Pass, Osnat Rosen, et al.
Scientific Reports|October 24, 2025
Elucidating the activation mechanism of botulinum neurotoxin a: role of α-clostripain and NTNHShani Pitel, Ada Barnea, Eran Diamant, et al.
Toxins|May 31, 2017
Role of Homologous Fc Fragment in the Potency and Efficacy of Anti-Botulinum Antibody PreparationsAmram Torgeman, Eyal Ozeri, Alon Ben David, et al.
Molecules (Basel, Switzerland)|June 2, 2021
Identification of SARS-CoV-2 Receptor Binding Inhibitors by In Vitro Screening of Drug LibrariesAlon Ben David, Eran Diamant, Eyal Dor, et al.
Disease Models & Mechanisms|August 18, 2018
Studying the differential efficacy of postsymptom antitoxin treatment in type A versus type B botulism using a rabbit spirometry modelAmram Torgeman, Arieh Schwartz, Eran Diamant, et al.
ALTEX|November 19, 2021
A cell-based alternative to the mouse potency assay for pharmaceutical type E botulinum antitoxinsEran Diamant, Amram Torgeman, Eyal Epstein, et al.
Pageof 3